Jan 8 (Reuters) - Kempharm Inc:
* KEMPHARM INITIATES PIVOTAL EFFICACY TRIAL OF KP415 * KEMPHARM INC - ENROLLMENT IN TRIAL IS EXPECTED TO TOTAL APPROXIMATELY 140 PATIENTS ACROSS FIVE CLINICAL SITES IN UNITED STATES Source text for Eikon: Further company coverage:
 